Drug news
FDA approves wider indication for fibrin sealant Tisseel (Baxter)
The FDA has approved Tisseel [Fibrin Sealant] from Baxter to include general hemostasis in surgery when control of bleeding by standard surgical techniques is ineffective or impractical.TISSEEL mimics the final stages of the body�s own blood clotting cascade, creating a clot that adheres to the wound surface and helps achieve hemostasis.